A case of aggressive systemic mastocytosis with bulky lymphadenopathy showing response to midostaurin

Management of systemic mastocytosis is an emerging challenge which requires a multidisciplinary diagnostic approach and personalized treatment strategy. Midostaurin can rapidly reduce the disease burden, also in cladribine refractory cases.

Saved in:
Bibliographic Details
Published in:Clinical case reports 2021, Vol.9 (2), p.978-982
Main Authors: Sciumè, Mariarita, Serpenti, Fabio, Muratori, Simona, Pravettoni, Valerio, Ulivieri, Fabio Massimo, Croci, Giorgio Alberto, Migliorini, Anna Chiara, Esposito, Andrea, Goldaniga, Maria Cecilia, Saporiti, Giorgia Natascia, Galassi, Giulia, Baldini, Luca, Onida, Francesco, Grifoni, Federica Irene
Format: Report
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Management of systemic mastocytosis is an emerging challenge which requires a multidisciplinary diagnostic approach and personalized treatment strategy. Midostaurin can rapidly reduce the disease burden, also in cladribine refractory cases.
ISSN:2050-0904
2050-0904
DOI:10.1002/ccr3.3717